The Patent Finder
US

Novel Angiopoietin 2, VEGF Dual Antagonists

US 12,043,662 In force
OverviewFamilyAssignmentsSources & methods

Term ends May 11, 2037 · High confidence

Filed Jul 13, 2021 as application 17/374,960 · Granted Jul 23, 2024
Base term plus 208 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2017 2037
Clock starts
May 11, 2017
Term ends
May 11, 2037
Granted
Jul 23, 2024
base term Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
208
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 11,059,885.
0 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 208 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts May 11, 2017, when application 15/593,280, the earliest non-provisional in its chain, was filed (this one was filed Jul 13, 2021)May 11, 2037High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+208 days, USPTO patent term adjustment recordDec 5, 2037High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 11,059,885)capped to May 11, 2037High confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events0 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderMay 11, 2037High confidence

This family

US 10,654,922In force
Oct 2037
Oct 2037
US 11,059,885In force
May 2037
May 2037
US 11,746,147In force
Sep 2038
Sep 2038
US 12,043,662this patent
May 2037
May 2037
US 12,715,912In force
May 2037
May 2037
Application 18/782,004Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Nov 12, 2021
Reel 58102, frame 36
Lu, Yuefeng; Lu, Jian-fengAskgene Pharma Inc.Assignment of Assignor's Interest
Oct 26, 2026
Reel 76509, frame 890
Askgene Pharma, Inc.Jiangsu Aosaikang Pharmaceutical Co., Ltd.Assignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited